Tag: Launch

  • Columbia Care Celebrates Launch of Adult Use Cannabis Sales in Missouri | News

    Columbia Care Celebrates Launch of Adult Use Cannabis Sales in Missouri | News

    NEW YORK–(Enterprise WIRE)–Feb 6, 2023–

    Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), just one of the premier and most experienced cultivators, manufacturers and stores of hashish goods in the U.S., introduced it commenced adult-use profits on February 4 at its Cannabist i dispensary, situated in Hermann, Missouri. The dispensary has been serving the clinical affected person group considering the fact that 2021.

    “We are thrilled to see the swift action taken by the Department of Health and Senior Companies to bring leisure hashish to Missourians so before long after the ballot measure passed in November. It has been a privilege to run in these types of a promptly escalating marketplace and serve our patients in the neighborhood Hermann group. We search ahead to welcoming new buyers as a result of our doorways in the coming weeks and introducing them to our Cannabist experience,” reported Jesse Channon, Main Expansion Officer, Columbia Treatment.

    Cannabist Hermann presents a extensive selection of solutions as well as manufacturers, which include Columbia Care’s Amber, Classix, Hedy and Seed & Pressure. In addition to its dispensary in Hermann, the Firm also operates a producing facility in nearby Columbia, Missouri, which produces vapes, edibles and pre-rolls.

    For much more data, pay a visit to https://gocannabist.com/hermann.

    i Cannabist Hermann is managed by Columbia Treatment, LLC on behalf of Columbia Care MO, LLC by way of a managed providers arrangement.

    About Columbia Care

    Columbia Care is 1 of the premier and most seasoned cultivators, makers and vendors of hashish goods and connected providers, with licenses in 18 U.S. jurisdictions. Columbia Care operates 128 services which includes 95 dispensaries and 33 cultivation and producing facilities, together with people beneath enhancement. Columbia Care is one particular of the initial multi-state vendors of health-related cannabis in the U.S. and now delivers industry-foremost goods and expert services to equally the medical and grownup-use markets. In 2021, the firm introduced Cannabist, its new retail brand, creating a national dispensary network that leverages proprietary know-how platforms. The business features goods spanning flower, edibles, oils and tablets, and manufactures popular models including Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Push, and Amber. For more information on Columbia Treatment, you should visit www.columbia.care.

    Caution About Ahead-Hunting Statements

    This push launch has certain statements that constitute “forward-looking information” or “forward-on the lookout statements” within the indicating of relevant securities laws and reflect the Company’s present-day expectations concerning future activities. Ahead-searching statements or information and facts contained in this release include, but are not restricted to, statements or info with regard to the Company’s ability to execute on retail, wholesale, manufacturer and product or service initiatives. These ahead-wanting statements or details, which even though considered sensible by the Firm, could verify to be incorrect and are matter to recognised and unknown hazards and uncertainties that may well result in actual outcomes, performance or achievements of the Firm to be materially various from those people expressed or implied by any ahead-wanting information. These risks, uncertainties and other factors include things like, amid other folks, favorable running and financial disorders acquiring and retaining all expected licenses and permits favorable manufacturing amounts and sustainable expenses from the Company’s functions and the amount of demand for hashish products and solutions, such as the Company’s items bought by third functions. In addition, securityholders ought to assessment the danger factors mentioned underneath “Risk Factors” in Columbia Care’s Kind 10 dated May perhaps 9, 2022, filed with the applicable securities regulatory authorities and described from time to time in documents submitted by the Firm with Canadian and U.S. securities regulatory authorities.

    Check out supply model on businesswire.com:https://www.businesswire.com/news/home/20230206005260/en/

    Get in touch with: Trader

    Lee Ann Evans

    Funds Marketplaces

    [email protected]

    Lindsay Wilson

    Communications

    +1.978.662.2038

    [email protected]

    Key phrase: UNITED STATES NORTH America NEW YORK MISSOURI

    Marketplace Search phrase: Alternate Medication Cannabis Health and fitness Buyer Women of all ages All-natural Sources Gentlemen

    Supply: Columbia Treatment Inc.

    Copyright Business enterprise Wire 2023.

    PUB: 02/06/2023 08:05 AM/DISC: 02/06/2023 08:04 AM

    http://www.businesswire.com/news/dwelling/20230206005260/en

    Copyright Enterprise Wire 2023.

  • Dr. Bill Rawls Announces Launch of Cellular Wellness Conversation Series

    Dr. Bill Rawls Announces Launch of Cellular Wellness Conversation Series

    Webinar collection will emphasize matters in wellbeing and wellness foremost up to the launch of new e-book The Cellular Wellness Answer

    RALEIGH, N.C., June 8, 2022 /PRNewswire/ — Dr. Bill Rawls, the Health care Director for on the net holistic well being corporation Vital Strategy, declared today the start of a discussion series that will count down to the June 21st release of his new ebook: The Cellular Wellness Alternative: Faucet Into Your Full Health and fitness Prospective with the Science-Backed Electricity of Herbs.                           

    “The sheer sum of conflicting wellness details that individuals are currently being bombarded with is overpowering, but the essential issue is truly extremely very simple: wellness commences at the mobile degree,” explained Dr. Rawls. “I wrote The Mobile Wellness Alternative to emphasize the crucial part our cells perform in supporting best overall health, and our want to emphasize keeping our mobile wellness as extended as we can to hold dwelling balanced life as we age.”

    The initially matter in the Mobile Wellness Solution Discussion Sequence: “A Sneak Peak at The Mobile Wellness Remedy will be available at 8PM ET/ 5PM PT on Wednesday, June 15, 2022. This very first celebration will function Dr. Rawls in conversation with Tim Yarborough of Important Program and signal up is free to all attendees. This webinar will:

    • Demystify the science and describes in simple English how our cells purpose, age, and deteriorate
    • Describe how keeping cellular wellness will allow you to sluggish down the growing older system – and improve your vitality so you really feel greater, and even appear younger
    • Display how to get off the hamster wheel of health and fitness fads and harness the purely natural cleaning and restorative powers of your possess cells
    • Aid viewers comprehend the therapeutic and restorative qualities located in herbs – attributes confirmed by the most up to date science and discoveries
    • Present easy to follow natural remedies and actions we can get to protect our personal cells – and our overall health. 

    “Our overall healthcare technique has gravitated towards prescribing drugs to handle and block fundamental indications, when not supplying men and women options to get management of their possess health and fitness,” stated Rawls. “Though prescription medicines are not prolonged-phrase options, the one of a kind homes of herbs boost healing at the mobile degree, supplying them a unique energy to reduce the incidence of all chronic illnesses, gradual getting old, and increase effectiveness.”

    Each and every webinar attendee will also get a likelihood to win a pre-launch duplicate of The Cellular Wellness Resolution.  You can register for the webinar right here. The Cellular Wellness Alternative will be produced on June 21, 2022 – indicator up at www.CellularWellness.com for an progress search at the ebook as nicely as specific giveaways and components as we count down to the start.

    ABOUT DR. Monthly bill RAWLS: A licensed health practitioner for about 30 many years, Monthly bill Rawls, MD has dedicated his daily life to medicine. When a health crisis in his early forties abruptly improved his high quality of life, he came experience to confront with the restrictions of modern day medication and began to discover the large options of substitute remedies. Restoring his wellness as a result of holistic and natural therapies influenced him to share his discoveries on the great importance of mobile wellness. Now, he will work to deliver health and vitality to other folks as he can help them establish their possess paths to wellness through contemporary herbology.  He is the author of the most effective-promoting Unlocking Lyme and the Professional medical Director of RawlsMD and Critical System, an on the net holistic wellbeing company and Certified B Company primarily based in Raleigh, NC. For additional on The Mobile Wellness Alternative, go to www.CellularWellness.com

    Source Important Prepare

  • VIVO Cannabis(TM) Announces Launch of Beacon Medical(TM) High-Dose CBD Oil and Pediatric Compassionate Care Program

    VIVO Cannabis(TM) Announces Launch of Beacon Medical(TM) High-Dose CBD Oil and Pediatric Compassionate Care Program


    Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.


    Toronto, Ontario–(Newsfile Corp. – November 23, 2021) – VIVO Cannabis Inc. (TSX: VIVO)(OTCQX: VVCIF) (“VIVO” or the “Company“), a leading provider of medical cannabis products and patient services, and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited (“Canna Farms”) and ABcann Medicinals Inc., today announced the launch of its newest medical cannabis product formulation: high-dose cannabidiol (CBD) oil under its Beacon Medical” brand.

    Beacon Medical” 2:100 high-dose CBD oil is a distillate-based cannabis oil containing 100 mg CBD and less than 2 mg tetrahydrocannabinol (THC). The entire family of Beacon Medical” oil products are formulated using a non-GMO, food-grade medium-chain triglycerides (MCT) carrier oil which results in the final product being both scentless and flavourless in taste.

    “With our commitment to the medical cannabis market, the team at VIVO aspires to deliver premium cannabinoid-based medical products to our patients, and the Beacon Medical” CBD+ | O has been launched in response to patient insights our team has collected over time,” commented Ray Laflamme, Canna Farms’ Co-Founder and VIVO’s Chief Executive Officer. “We recognize that many of our patients are looking for products that meet their individualized needs, and this latest addition to the Beacon Medical family of products is an excellent high potency CBD option for patients and it will be available to patients, doctors, and hospitals alike.”

    Cannot view this image? Visit: https://orders.newsfilecorp.com/files/3063/104861_d6d7d616944e29cd_002.jpg

    Beacon CBD +|O [2:100] Extra-strength CBD oil to help patients achieve their health objectives

    To view an enhanced version of this graphic, please visit:
    https://orders.newsfilecorp.com/files/3063/104861_d6d7d616944e29cd_002full.jpg

    VIVO simultaneously announced the launch of a Pediatric Compassionate Care Program to support caregivers and families requiring medical cannabis to treat a variety of pediatric conditions. Eligible patients will receive substantial discounts off all Beacon Medical”, Canna Farms”, Fireside” and Lumina” CBD products.

    VIVO stands strong on its patient-first approach ensuring choice, access, and consistent supply for patients. Beacon Medical” products are available exclusively in select medical markets in Canada, Australia & Germany.

    This newly launched Beacon Medical” high CBD oil is available through the Canna Farms e-commerce medical marketplace for Canadian medical clients. Patients requiring support with registration or placing orders can contact VIVO’s Customer Care Team at 1 (855) 882-0988 or [email protected].

    About VIVO Cannabis”

    VIVO Cannabis” is recognized for trusted, premium cannabis products and services. It holds production and sales licences from Health Canada and operates world-class indoor and seasonal airhouse cultivation facilities. VIVO has a collection of medical, health and wellness brands, each targeting different customer segments, including Canna Farms”, Beacon Medical”, Fireside”, and Lumina”. Harvest Medicine”, VIVO’s patient-centric, scalable network of medical cannabis clinics, has serviced over 150,000 patient visits. VIVO is pursuing several partnership and product development opportunities and is focusing its international efforts on Germany and Australia. For more information visit: www.vivocannabis.com.

    For further information:

    VIVO Investor Relations
    +1 416-848-9839
    [email protected]

    Instagram: https://www.instagram.com/vivo_cannabis/
    Facebook: https://www.facebook.com/vivocanna/
    Twitter: https://twitter.com/vivo_cannabis
    LinkedIn: https://www.linkedin.com/company/vivo-cannabis-inc/

    Disclaimer for Forward-Looking Information

    Certain statements in this news release are forward-looking statements, which are statements that are not purely historical, including statements regarding the beliefs, plans, expectations or intentions of VIVO and its management regarding the future. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forwardlooking statements. No assurance can be given that any of the events anticipated by the forwardlooking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are urged to consider these factors carefully along with the more extensive risk factors included in the Company’s most recent management’s discussion and analysis available on SEDAR, in evaluating the forwardlooking statements contained in this news release and are cautioned not to place undue reliance on such forwardlooking statements, which are qualified in their entirety by these cautionary statements. The forwardlooking statements in this news release are made as of the date hereof and the Company disclaims any intent or obligation to update publicly any such forwardlooking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws.

    To view the source version of this press release, please visit https://www.newsfilecorp.com/release/104861